This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
It’s no secret that the rate of cancer both in Australia, and overseas, appears to be increasing – particularly among...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PCC | bioshares report | 11/04/12 | 1 | 1.3K | |||
|
|||||||
PCC | Ann: Becoming a substantial holder | 04/04/12 | 0 | 602 | |||
|
|||||||
PCC | Ann: New Australian Drug Developer Lists on ASX | 04/04/12 | 0 | 639 | |||
|
|||||||
PCC | Ann: Becoming a substantial holder | 04/04/12 | 0 | 556 | |||
|
|||||||
PCC | Ann: Share Trading Policy | 03/04/12 | 0 | 508 | |||
|
|||||||
PCC | Ann: Constitution of Company | 03/04/12 | 0 | 537 | |||
|
|||||||
PCC | Ann: Completion of Takeover of Hunter Immunology | 03/04/12 | 0 | 653 | |||
|
|||||||
PCC | Ann: Pre-Quotation Disclosure | 03/04/12 | 0 | 466 | |||
|
See All Discussions